Date: April 27-30
Location: Barcelona, Spain
Attending
- Laurie Sarrat, Business Development Manager
- Helen Box, Business Development Executive
- Nadir Bessila, Senior Manager Business Development | Anti-Infectives
- Pia Thommes, VP Anti-Infectives
- Francesca Bernardini, VP In vitro Biology
- Isabelle Erbetti, Senior Manager In Vitro Biology
- Hugh Watson, Principal Manager of Clinical Development
- Aurelie Couturier, Group Leader Anti-Infectives
Evotec will be presenting
|
Session type: Poster Session Abstract Title: Prospective evaluation of serum cytokines and musculoskeletal ultrasound as surrogate markers for chronic post-Chikungunya rheumatism Presenter: Hugh Watsons, Principal Manager of Clinical Development |
Session type: Poster Session Abstract Title: Assessment of zosurabalpin activity in combination with other antibiotics |
ESPRI-IOAC will be presenting
|
Session title: Basic science studies using Omics (in vitro and in vivo) Abstract Title: Bacterial transcriptomics in staphylococcal bone and joint infections: translational experiments from exponential in vitro culture to in vivo infection Date and Time: April 30th, 12.00
|